Cargando…

Impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery

The aim of this study was to explore the impact of 3% hypertonic saline (HS) intragastric administration for patients who underwent upper gastrointestinal surgery. During the postoperative period, 3% HS has been suggested as a means to improve the intestinal edema and reduce gastrointestinal complic...

Descripción completa

Detalles Bibliográficos
Autores principales: Hong, Siqi, Shang, Qingjuan, Geng, Qiankun, Yang, Yang, Wang, Yan, Guo, Chunbao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371437/
https://www.ncbi.nlm.nih.gov/pubmed/28328800
http://dx.doi.org/10.1097/MD.0000000000006121
_version_ 1782518419365560320
author Hong, Siqi
Shang, Qingjuan
Geng, Qiankun
Yang, Yang
Wang, Yan
Guo, Chunbao
author_facet Hong, Siqi
Shang, Qingjuan
Geng, Qiankun
Yang, Yang
Wang, Yan
Guo, Chunbao
author_sort Hong, Siqi
collection PubMed
description The aim of this study was to explore the impact of 3% hypertonic saline (HS) intragastric administration for patients who underwent upper gastrointestinal surgery. During the postoperative period, 3% HS has been suggested as a means to improve the intestinal edema and reduce gastrointestinal complications. The medical records of 111 patients with HS intragastric administration following upper gastrointestinal surgery and 268 patients, served as control, were reviewed retrospectively. Propensity score matching was performed to adjust for selected baseline variables. Clinical outcomes, including early gastrointestinal function recovery, postoperative complications, and length of hospital stay, were compared according to the HS intragastric administration or not. HS intragastric administration was associated with prompt postoperative gastrointestinal function recovery, including first flatus (risk ratio [RR], 1.32; 95% confidence interval [CI], 0.89–1.65; P = 0.048) and feeding within 3 postoperative days (RR (95% CI), 0.57 (0.49–0.77); P = 0.036). Early ileus occurred in 25 of 108 patients with HS treatment versus 36 of 108 patients without HS treatment (RR (95% CI), 1.43 (0.63–2.15); P = 0.065). The patients with HS experienced a lower overall postoperative complication (odds ratio [OD] 0.57; 95% CI, 0.33–1.09; P = 0.063), including trend toward a decrease for infectious complications (15[13.9] vs 23[21.3]; P = 0.11; OD, 0.59; 95% CI, 0.29–1.22). There was a decreased incidence of anastomotic leakage (1[0.9] vs 7[6.5]; P = 0.033) and postoperative ileuas (5[4.6%] vs 11[10.2%]; P = 0.096) in the HS administration patients. Our study demonstrated beneficial postoperative clinical effects of HS intragastric administration in patients who had undergone upper gastrointestinal surgery, such as prompt postoperative gastrointestinal function recovery and reduced overall postoperative complications, which may be attributed to a reduced intestinal edema.
format Online
Article
Text
id pubmed-5371437
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-53714372017-04-03 Impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery Hong, Siqi Shang, Qingjuan Geng, Qiankun Yang, Yang Wang, Yan Guo, Chunbao Medicine (Baltimore) 4500 The aim of this study was to explore the impact of 3% hypertonic saline (HS) intragastric administration for patients who underwent upper gastrointestinal surgery. During the postoperative period, 3% HS has been suggested as a means to improve the intestinal edema and reduce gastrointestinal complications. The medical records of 111 patients with HS intragastric administration following upper gastrointestinal surgery and 268 patients, served as control, were reviewed retrospectively. Propensity score matching was performed to adjust for selected baseline variables. Clinical outcomes, including early gastrointestinal function recovery, postoperative complications, and length of hospital stay, were compared according to the HS intragastric administration or not. HS intragastric administration was associated with prompt postoperative gastrointestinal function recovery, including first flatus (risk ratio [RR], 1.32; 95% confidence interval [CI], 0.89–1.65; P = 0.048) and feeding within 3 postoperative days (RR (95% CI), 0.57 (0.49–0.77); P = 0.036). Early ileus occurred in 25 of 108 patients with HS treatment versus 36 of 108 patients without HS treatment (RR (95% CI), 1.43 (0.63–2.15); P = 0.065). The patients with HS experienced a lower overall postoperative complication (odds ratio [OD] 0.57; 95% CI, 0.33–1.09; P = 0.063), including trend toward a decrease for infectious complications (15[13.9] vs 23[21.3]; P = 0.11; OD, 0.59; 95% CI, 0.29–1.22). There was a decreased incidence of anastomotic leakage (1[0.9] vs 7[6.5]; P = 0.033) and postoperative ileuas (5[4.6%] vs 11[10.2%]; P = 0.096) in the HS administration patients. Our study demonstrated beneficial postoperative clinical effects of HS intragastric administration in patients who had undergone upper gastrointestinal surgery, such as prompt postoperative gastrointestinal function recovery and reduced overall postoperative complications, which may be attributed to a reduced intestinal edema. Wolters Kluwer Health 2017-03-24 /pmc/articles/PMC5371437/ /pubmed/28328800 http://dx.doi.org/10.1097/MD.0000000000006121 Text en Copyright © 2017 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by-sa/4.0 This is an open access article distributed under the Creative Commons Attribution-ShareAlike License 4.0, which allows others to remix, tweak, and build upon the work, even for commercial purposes, as long as the author is credited and the new creations are licensed under the identical terms. http://creativecommons.org/licenses/by-sa/4.0
spellingShingle 4500
Hong, Siqi
Shang, Qingjuan
Geng, Qiankun
Yang, Yang
Wang, Yan
Guo, Chunbao
Impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery
title Impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery
title_full Impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery
title_fullStr Impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery
title_full_unstemmed Impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery
title_short Impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery
title_sort impact of hypertonic saline on postoperative complications for patients undergoing upper gastrointestinal surgery
topic 4500
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5371437/
https://www.ncbi.nlm.nih.gov/pubmed/28328800
http://dx.doi.org/10.1097/MD.0000000000006121
work_keys_str_mv AT hongsiqi impactofhypertonicsalineonpostoperativecomplicationsforpatientsundergoinguppergastrointestinalsurgery
AT shangqingjuan impactofhypertonicsalineonpostoperativecomplicationsforpatientsundergoinguppergastrointestinalsurgery
AT gengqiankun impactofhypertonicsalineonpostoperativecomplicationsforpatientsundergoinguppergastrointestinalsurgery
AT yangyang impactofhypertonicsalineonpostoperativecomplicationsforpatientsundergoinguppergastrointestinalsurgery
AT wangyan impactofhypertonicsalineonpostoperativecomplicationsforpatientsundergoinguppergastrointestinalsurgery
AT guochunbao impactofhypertonicsalineonpostoperativecomplicationsforpatientsundergoinguppergastrointestinalsurgery